Shanghai C&D Innostic Medical Technology (SHE:301584) plans to offer up to 63,193,277 shares in an initial public offering on the Shenzhen Stock Exchange.
The shares on offer will be equivalent to 15% of the entire shareholding of the medical supplies company.
Following the IPO, Innostic will have 421,288,509 shares.
CITIC Securities (HKG:6030, SHA:600030) is the sponsor and lead underwriter of the offering.